All Categories Archives - Page 25 of 290

Mitochondria-derived peptide MOTS-c alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice by activating Nrf2 pathway

Dan Chen, Mei-hui Zhou, Wei-ying Zhu, Zhi-xuan Xing, Sheng-peng Li, Ya-xian Wu, Xiao-lin Sun, Ping Sun, Qing-feng PangWuxi School of Medicine, Jiangnan University Medical Center and Jiangnan University. Maternity and Child Health Care Affiliated Hospital, Jiaxing University. Linyi Maternal and Child Health Hospital. China European Journal of PharmacologyEur J Pharmacol 2026; DOI: 10.1016/j.ejphar.2026.178726 AbstractOxidative stress play […]

Mitochondria-derived peptide MOTS-c alleviates hyperoxia-induced bronchopulmonary dysplasia in neonatal mice by activating Nrf2 pathway Read More »

Respiratory Syncytial Virus Infection Triggering a Pulmonary Hypertensive Crisis in a Boy With Prader-Willi Syndrome-Associated Sleep-Disordered Breathing

Mari Tsukahara, Hideaki Yagasaki, Koichi Makino, Tomoaki Sano, Takeshi InukaUniversity of Yamanashi.Japan CureusCureus 2026; 18: DOI: 10.7759/cureus.103890 AbstractPrader-Willi syndrome (PWS) is a multisystem genetic disorder frequently complicated by sleep-disordered breathing, including obstructive sleep apnea. Respiratory infections may precipitate acute decompensation in vulnerable patients with PWS. A four-year-old boy with genetically confirmed PWS receiving growth hormone therapy

Respiratory Syncytial Virus Infection Triggering a Pulmonary Hypertensive Crisis in a Boy With Prader-Willi Syndrome-Associated Sleep-Disordered Breathing Read More »

Updates in the Treatment of Pediatric Pulmonary Arterial Hypertension

Danya Z. Jafri, James M. Beck, Samantha A. Kaplan, Allegra Keeler, Bryan Sanchez, Daniela Brady, William H. Frishman, Wilbert S. Aronow, Avi Levine, Erika Rosenzweig, Gregg M. LanierNew York Medical College School of Medicine. Westchester Medical Center.United States Cardiology in ReviewCardiol Rev 2026; DOI: 10.1097/CRD.0000000000001239 AbstractPediatric pulmonary arterial hypertension (PAH) is a relentless and potentially fatal

Updates in the Treatment of Pediatric Pulmonary Arterial Hypertension Read More »

Pulmonary Hypertension in Pediatric Patients with Noonan Syndrome Undergoing Cardiac Catheterization

Shane L. Collins, Paul J. Critser, Kimberlee Gauvreau, Diego Porras, Amy E. Roberts, Mary P. MullenBoston Children’s Hospital and Harvard Medical School. Cincinnati Children’s Hospital and University of Cincinnati College of Medicine. United States Pediatric CardiologyPediatr Cardiol 2026; DOI: 10.1007/s00246-026-04235-x AbstractNoonan syndrome (NS) is an autosomal dominant genetic disorder associated with a high incidence of cardiovascular

Pulmonary Hypertension in Pediatric Patients with Noonan Syndrome Undergoing Cardiac Catheterization Read More »

Neonatal pulmonary vascular remodeling induced by increased blood flow is associated with an antiviral-like immune signature

Sixie Zheng, Hao Li, Siqi She, Yiting Xue, Debao Li, Jiapei Wang, Jing Wang, Yuqing Hu, Lincai YeShanghai Children’s Medical Center and Shanghai Jiao Tong University School of Medicine. Children’s Hospital of Fudan University and National Children’s Medical Center. Affiliated Women and Children’s Hospital of Ningbo University. China Frontiers in ImmunologyFront Immunol 2026; 17: DOI: 10.3389/fimmu.2026.1780303

Neonatal pulmonary vascular remodeling induced by increased blood flow is associated with an antiviral-like immune signature Read More »

Lung ultrasound score ≥ 6 predicts surfactant administration decisions in meconium aspiration syndrome: a multicenter prospective study

Qi Chen, Zekai Yu, Lei Cao, Wei Xiong, Mei Zheng, Fei Wang, Shasha Wu, Rijin Yu, Minli Zhou, Cheng Guo, Lin Dong, Shuang LiuShangrao Children’s Hospital and Shangrao Maternal and Child Health Hospital. Hangzhou Dianzi University. Jingdezhen First People’s Hospital. Hubei University of Medicine. Xiangyang First People’s Hospital. Qinghai Red Cross Hospital. Yangzhou Maternal and

Lung ultrasound score ≥ 6 predicts surfactant administration decisions in meconium aspiration syndrome: a multicenter prospective study Read More »

Pulmonary Hypertension Associated With Vitamin C Deficiency Is Rapidly Reversible

Tomás Woodgate, Jay Patel, Thomas Day, Brodie Knight, Adriani Spanaki, Alistair Calder, Shahin Moledina, Sadia QuyamGreat Ormond Street Hospital. Royal Hospital for Children. Evelina London Children’s Hospital,United Kingdom PediatricsPediatrics 2026; DOI: 10.1542/peds.2025-073645 AbstractWe report 4 children (aged 3-9 years) with severe pulmonary hypertension (PH) associated with vitamin C deficiency. All presented with either musculoskeletal symptoms or

Pulmonary Hypertension Associated With Vitamin C Deficiency Is Rapidly Reversible Read More »

Animal models of chronic thromboembolic pulmonary hypertension

Yong-Jian Zhu, Lin-Chao Zhou, Xiao-Xue Zhang, Xiao-Yang Ren,Yi Yan, Shao-Fei LiuFirst Affiliated Hospital of Zhengzhou University. Henan Provincial People’s Hospital. Shanghai Children’s Medical Center, National Children’s Medical Center and Shanghai Jiao Tong University School of Medicine. Changhai Hospital and Naval Medical University.China Animal Models and Experimental MedicineAnimal Model Exp Med 2026; DOI: 10.1002/ame2.70167 AbstractChronic thromboembolic pulmonary

Animal models of chronic thromboembolic pulmonary hypertension Read More »

Non-Extremity Thrombosis Sequelae in Children: Screening, Diagnosis, and Management

Riten Kumar, Vilmarie Rodriguez, Clay Cohen, Madhvi Rajpurkar, Ayesha ZiaBoston Children’s Hospital and Harvard Medical School. Nationwide Children’s Hospital and Ohio State University. Texas Children’s Hospital and Baylor College of Medicine. Central Michigan University, Children’s Hospital of Michigan and Wayne State University. University of Texas Southwestern.United States Journal od Thrombosis and HemostasisJ Thronb Hemost 2026;

Non-Extremity Thrombosis Sequelae in Children: Screening, Diagnosis, and Management Read More »